CSIMarket
 


H cyte Inc  (HCYT)
Other Ticker:  
 
 

HCYT's Net Income Growth by Quarter and Year

H Cyte Inc's Net Income results by quarter and year




HCYT Net Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -1.49 -0.75 -1.52
III Quarter September - -2.28 -0.59 3.91
II Quarter June - -2.64 -2.06 -6.55
I Quarter March -2.09 -3.89 -1.41 -2.57
FY   -2.09 -10.30 -4.81 -6.73



HCYT Net Income first quarter 2022 Y/Y Growth Comment
H cyte Inc in the first quarter 2022 recorded net loss of $ -2.09 millions.

According to the results reported in the first quarter 2022, H Cyte Inc achieved the best Net Income growth in Medical Equipment & Supplies industry. While H Cyte Inc' s Net Income no change of % ranks overall at the positon no. in the first quarter 2022.




HCYT Net Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
H Cyte Inc's first quarter 2022 Net Income $ -2.09 millions HCYT's Income Statement
H Cyte Inc's first quarter 2021 Net Income $ -3.89 millions Quarterly HCYT's Income Statement
New: More HCYT's historic Net Income Growth >>


HCYT Net Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

H Cyte Inc's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HCYT's I. Quarter Q/Q Net Income Comment
Current accomplishment of -2.09 millions by H cyte Inc look even less good if you take a look at -1.49 millions a quarter before.

Within Medical Equipment & Supplies industry H cyte Inc achieved highest sequential Net Income growth. While H Cyte Inc's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


HCYT's I. Quarter Q/Q Net Income Comment
I. Quarter 2022 results of -2.09 millions by H cyte Inc appear even less good compare to the -1.49 millions net loss in the previous quarter.

Within Medical Equipment & Supplies industry H cyte Inc achieved highest sequential Net Income growth. While H Cyte Inc's Net Income growth quarter on quarter, overall rank is .


H Cyte Inc's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Net Income 12 Months Ending $ -8.50 $ -10.30 $ -9.55 $ -7.86 $ -7.28
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
H Cyte Inc' has realized cumulative trailing twelve months net loss of $ -9 millions in the Mar 31 2023 period.

H cyte Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
H Cyte Inc' has realized cumulative trailing twelve months net loss of $ -9 millions in the Mar 31 2023 period.

H cyte Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Medical Equipment & Supplies Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
HCYT's Net Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for HCYT's Competitors
Net Income Growth for H Cyte Inc's Suppliers
Net Income Growth for HCYT's Customers

You may also want to know
HCYT's Annual Growth Rates HCYT's Profitability Ratios HCYT's Asset Turnover Ratio HCYT's Dividend Growth
HCYT's Roe HCYT's Valuation Ratios HCYT's Financial Strength Ratios HCYT's Dividend Payout Ratio
HCYT's Roa HCYT's Inventory Turnover Ratio HCYT's Growth Rates HCYT's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2023
Intuitive Surgical Inc -2.33%$ -2.328 millions
U S Physical Therapy Inc-4.63%$ -4.632 millions
Zoetis Inc -7.24%$ -7.239 millions
Innoviva Inc -7.91%$ -7.906 millions
Vertex Pharmaceuticals Inc-8.17%$ -8.175 millions
Edwards Lifesciences Corporation-8.86%$ -8.860 millions
Lifevantage Corp-10.43%$ -10.429 millions
Iqvia Holdings Inc -11.08%$ -11.077 millions
Viemed Healthcare Inc -13.90%$ -13.905 millions
Insulet Corporation-14.39%$ -14.388 millions
Chemed Corporation-15.66%$ -15.659 millions
Regeneron Pharmaceuticals Inc -15.99%$ -15.994 millions
Davita Inc -17.04%$ -17.038 millions
National Research Corporation-18.44%$ -18.445 millions
West Pharmaceutical Services Inc -19.45%$ -19.448 millions
Amedisys Inc -21.45%$ -21.455 millions
Dariohealth Corp -21.64%$ -21.641 millions
Biomx Inc -22.13%$ -22.132 millions
3m Company-24.71%$ -24.712 millions
Integra Lifesciences Holdings Corp-26.37%$ -26.367 millions
National Healthcare Corp-26.48%$ -26.477 millions
Eli Lilly And Company-29.32%$ -29.324 millions
Pacific Health Care Organization Inc -30.46%$ -30.459 millions
Corcept Therapeutics Inc-30.66%$ -30.662 millions
Synaptogenix Inc -31.54%$ -31.544 millions
Supernus Pharmaceuticals inc -33.84%$ -33.838 millions
Halozyme Therapeutics Inc -34.09%$ -34.094 millions
Merck and Co Inc -34.50%$ -34.500 millions
Align Technology inc -34.62%$ -34.624 millions
Avantor Inc -36.19%$ -36.187 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com